当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第34期
编号:12989701
心脏X综合征的中西医诊治进展(3)
http://www.100md.com 2016年8月27日 《医学信息》 2016年第34期
     [3]Chen YX,Luo NS,Lin YQ,et al.Selective estrogen receptor modulators promising for cardiac syndrome X[J].Journal of postgraduate medicine,2010,56(4):328-33

    [4]Di Monaco A,Bruno I,Calcagni ML,et al.Cardiac adrenergic nerve function in patients with cardiac syndrome X[J].Journal of cardiovascular medicine(Hagerstown,Md.),2010,11(3):151-156.

    [5]Arthur HM,Campbell P,Harvey PJ,et al.Women,cardiac syndrome X,and microvascular heart disease[J].The Canadian journal of cardiology, 2012,28(2 Suppl):S42-49.
, http://www.100md.com
    [6]Cotrim C,Almeida AG,Carrageta M.Cardiac syndrome X,intraventricular gradients and,beta-blockers.Revista portuguesa de cardiologia:orgao oficial da Sociedade Portuguesa de Cardiologia[J].Portuguese journal of cardiology:an official journal of the Portuguese Society of Cardiology,2010,29(2):193-203.

    [7]Kaski JC,Rosano GM,Collins P,et al.Cardiac syndrome X:clinical characteristics and left ventricular function.Long-term follow-up study[J].Journal of the American College of Cardiology, 1995,25(4):807-814.
, http://www.100md.com
    [8]Russo G,Di Franco A,Lamendola P,et al.Lack of effect of nitrates on exercise stress test results in patients with microvascular angina[J].Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy, 2013,27(3):229-234.

    [9]Pauly DF,Johnson BD,Anderson RD,et al.In women with symptoms of cardiac ischemia,nonobstructive coronary arteries,and microvascular dysfunction,angiotensin-converting enzyme inhibition is associated with improved microvascular function:A double-blind randomized study from the National Heart,Lung and Blood Institute Women's Ischemia Syndrome Evaluation(WISE)[J].American heart journal,2011,162(4):678-684.
, http://www.100md.com
    [10]Zhang X,Li Q,Zhao J,et al.Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X[J].Coronary artery disease,2014,25(1):40-44.

    [11]Agrawal S,Mehta PK,Bairey Merz CN.Cardiac Syndrome X:update 2014[J].Cardiology clinics,2014,32(3):463-478.

    [12]朱曉红,贾燕平.血府逐瘀汤加减治疗心脏X综合征30例临床观察[J].河南中医学院学报,2003,2(3):105.

    [13]苏立硕.中医药治疗心脏X综合征验案1则[J].湖南中医杂志,2014,30(12):83-84.
, http://www.100md.com
    [14]陈文梅,金鸣,吴伟,等.红花黄色素抑制血小板激活因子介导的血小板活化作用的研究[J].中国药学杂志,2000,35(11):741-744.

    [15]张军惠,王立君,韩建妙.益心舒胶囊治疗女性心脏X综合征的临床疗效[J].中西医结合心脑血管病杂志,2013,11(6):692-693.

    [16]王楠,周照丽,唐文博,等.益心舒胶囊与氟伐他汀对动脉粥样硬化内皮功能的影响[J].疑难病杂志,2011,10(3):203-205.

    [17]许涛,俞莉.丹参对治疗性动脉粥样硬化形成的预防[J].临床心血管杂志,2005,21(1):54-55.

    [18]田清涞.某些天然食物和中草药对小鼠心肌脂褐质含量的影响[J].老年学杂志,1986(5):26-28.
, 百拇医药
    [19]许伟源,郭航远,彭放.益心舒胶囊对冠心病患者血管内皮功能改善作用的研究[J].中国医院用药评价与分析,2010,10(12):1112-1113.

    [20]于辉,张红霞,张磊.益心舒胶囊对冠心病心绞痛血管内皮功能影响的观察[J].人民军医,2011,54(2):120-121.

    [21]范俊,张小燕,张志杰,等.麦冬不同提取部位对过氧化氢所致血管内皮细胞损伤的保护作用[J].中国药理学与毒理学杂志,2007,21(2):131.

    [22]李文明,刘洪涛,李佳佳,等.川芎有效成分的体外抗氧化研究[J].食品与生物技术学报2010,29(1):64-65.

    [23]李树青.黄芪对冠心病心绞痛患者血清SOD和LPO的作用[J].中西医结合心脑血管病杂志,2003,1(1):23-24.编辑/蔡睿琳, http://www.100md.com(张进)
上一页1 2 3